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wimlorr-s”kv?t. Ntvr,, < i,nr,i,w 
is Unlikely that b~diiiwl 
fxkmeis s6ectrd expetimentd naulb. ikauw Batments 
were rm~domked, it it unlii thal proBrcssion or rrggsion 
of cwonuy attet~ stbetcsdcttzir dutiag the apetimettt af- 
feckd expetimctttal tmuhs. 
Tbe. kdmenk were a8 fdla: 1) 110 hamom mplace- 
mar 2) co&sated wdm c&xca~ (Ptcmmin, Wyeth- 
4) r&ibiwomj* equine cstt+ and cyclic high tka 
MPA; and 5) mmbhlcd cimjugmed eqtdne MtlweM and “la 
das” mnti~uma MPA (0.i ~jqhknim 25 mg d 
Mf’wday in wonen. 
Blcad sample1 c &ma oobceakmlom of eattt&l (a 
mctabolik of c+gated equine estmgenr) and MPA were 
analyzed accwdbu to mwiouly dcatbd methods [3811). 
dronny u$&&. on -day 26 of eadl ttemilm~ pp 
riad, wtway Pilgiogmphy was performsa to nuawn the 
etlect of the hotmoue tqducement regimen8 ~1 cndothclhmv 
medinted and smooth muscle-mediated dilation of tba left 
circumtka miunuy rutmy. Cotawry angiogmphy was per- 
famed immedla~& after t&inn bkmd ant&t fat tdmmn 
lipid and sex ho& detetmitt&ns. Sup&mental doses of 
ketaminermdburmphanolwete@vc\znwmabttainlightswgi. 
Cal anestbeain. M@ilkcjs were allowed to btcatbe spalta”o- 
aulyandmnwatmedbyacimda~wterbb&t.lheusc 
uf quamib3tivc cmuaty mlgiogt~ to mcasutc lxlmnaq 
mtety teactivity has been hactiid ekmvbxe and validaed in 




479 mm uetz ohtained u&t mdiagmph copdicioas (K.V.P. 
attd~)simillrtothmcinmotdteyat@g@y.Tbc 
.mTahm~ntnuo.9Rwitbaltandudumrd 
do&g MPA or coojugared equine estrcgen plw WPA treat- 
menui @ < 0.05 vs. control) (Table I). Plasma concentratiom 
of MPA wm hiikr dorkg high dw than low dose MPA 
treannents (p < O&5) (Tobk I). 
Corwuy am&rap@. The baol diometen of mmoary 
arterks (b&m soy of the anuncnl rcgimcos) was 1.3 -z 
R2 mm. F-1 diameters did not chaogc sigoifimtly during the 
di&mt intervm~ionr (p > 0.0s). Results of IO-’ and 
IO-’ n&liter of acetylchdine on axunmy a*ry ractivhy 
were mn sigoificam (p > O.C6) (Tabk I). Commy orwrits 
coostrickd to IV6 moiiliter of ocelylcholine ticn mook~ys 
rccciwl PO homxmal replacement bto dilated doring conju- 
@cd equine &mgm treahnent (p < 0.05 vs. comml) (Fi& 1). 
Trealoxol with high dose cyclic MPA did oat signilicantiy 
improve -my am XI- to xctyichdine (p > 0.05 VI. 
somml) (Fig. 1). Hcwvcr. additioo of cyclic hii bse VI 
cootiouws tow dose WA 10 conjugated equine estrugcn 
trcamwnt diiinishcd t!~ bcndicii cffcct of conjugated 
quint v 08 acetykholii4ndoced dilation of mhx* 
&mtic mmmy art&s (p < OflS vs. co@gated equine 
cstmgcns) (Fii 2). There were oo ueatmeilt effects on 
i -!- 
dilator responses to nitmglycerin (for all. p > Il.!3 vs. 
contrul) (Tabk I). 
77~ jbur mujo JimI& of this study urrc that mmg 
rwginlly po~tmmopaosal fmmk monLeyr with din-induced 
cwonaly artcry atbermckmsk I) orol administration of coo- 
jugatsd equirr estmgens improved endotheliom-medkted di. 
lstion of commuy art&s: 2) oral administration of a progw 
lin did not impmvc impaired endothcliim-mediated iiidon: 
howxr. 3) additioo of a progesth (given cyclicrdly or co&- 
unurly) to the est- rqimen diminished lhc ben&ial 
cffccts of unopposed catrogun on cododwlium-mcdiafed ilo- 
ticax and 4) oral ;Idmhdstmtion of an eswogco or pmgestin, or 
iulh. had no e&et on erdothelium-independent dilolion of 
rlhomsckrodc cornnary ar!ties 
Repeal cnmmoy artery angiography allows repeated men- 
surcs of coromuy artery reactivity within rhe same monkey ood 
incsases lhc power of ohpewatiow. Bccawsc UIcrc was 110 
washout period between trcatmmtx the c&r d t~~abne”D 
WSI random&d to reduce the podilitks tk; I) ‘k crab ill 
treatment M coronary artcry~re.activity were dw tti residual 
effezts of the orevious twatmcnt; 2) progmssive damage to the 
conmary artery endotheliom by th; &II&x atTeaed &mnrry 
~nerv reactivily and 3) om.vesskm ofcoronw artery athero- 
&is d&g the &&i&n1 wss not a v&iabk~a&ting 
corcmw srtew reactivity. Xx belief that widusl effects of 
treatment on &nary artery reactivity were minimal is sup 
pmted by the finding that there were no difcrenoes in plasma 
lipoprotein, esasdid (,I tiPA concentrations du:ing barline 
(bcforr any troahnent) and control (done a ulying times 
during the expedmmt). Fwthermom. this fmdiw indioltes 
tbzt I month was a sufficient time to wash out the pmiour 
tnatmenL 
Unlii tbc present study, earlier studies (l-3) bnw exam. 
ined the e&cts of Pmwtcml admhistration of estrogen (ot 
md oral and puenteml admittiition of estrogen) on 
cnduthelium-mediated dilwian ofmmmwv arteries. Ftesults d 
thccumntstudysmcnd thoscofpm/lottshudic.sbyerolminbtg 
the separate and ccmbincd cUsts of maI administratwn of 
conjogatcd equine estrogens and a pm&n on coronary 
nrte~mactiviii. fmprrta~tly. the present study cxaminc.s tltc 
&as of tw common oroqeskin reqbttens (cyclic and contin- 
uowMPA)onumma~a&ryreaclitily in&nkcysrcceivin~ 
amjugated equine cstmgens. 
E&d6 of estrogen. fnn.+m~ (33 monlh) sutcotaneoos 
administration of I7-beta cstrsdiol to postmenopsusal 
monkey improws endothelium-mediated dilation of athero- 
sclerotic coronary artorks (2). Funhemtore, endotheliom- 
mediated dilstion of atherademtic coronary nrteties is im- 
pmwd 20 min after intmvmtoiu infusion of ctbiiyl candid 
(3). This et&t of estmgen teplwmwd on endotheliom- 
medinted dilation of athemsdemtir conmay arteries has been 
Eonfirmed in pwtttenopawd wmcn (1). In w.w pmkws 
studies (12). estrogen wns given at pbysiok#ic dmu that 
Molted in plasma estmdiol conccntmtkms similar to those of 
peak follicokw phnse estrogen (-920 pm&liter). Pbamtam. 
lo& doses of 17-k& estradiol have been shown to improve 
studied in vitro, &.sfbly by actwaring ion channels il2). ll!-z 
results of tbs Present esperimcnt sopport those of prevkws 
studies by showing that physlologlc doses of oral conjugated 
equine estrogens improve csdothclium-meditcd dllmion of 
nthemxlerotic cornnary arteries studied in viva. Homver, it 
remaim ottckar why this is so, when by contmst. high doses of 
estrogen aRect &helium-independent dilation of non& 
crc6c!erotic uteries when studied in vitro. Rrhsps the dose of 
estmgen or the disease state of the attq affects estrogen- 
mediated vacculor wpmws of arterks. 
‘DE magnitude of improvement in endothelium-mediated 
dilation reported in tbe present e&mutt (II%) was within 
the sensitivity range of the quantitative mtgiogmphy methods 
but was less than in previous experiments that showed a 30% 
to 33% (2) and 21% (3) improvement after prentend &tin- 
istmtiott of estradiol. Tlx physiologic i-we of these 
smaller httprovemer.ts in “ponr to oral mnjugakd equim 
estrogens is undrar. -Icholine is a test substance only. Any 
impro~nt or G%painoent of dfftion doe to acctyicboline 
canbc intqwtedo.dyasan tirofcoronary artery function. 
In this sew, any imprcwment OT impairment in comnmy 
function a-add be phyxiolngica$ impartant in tbe pathogene- 
sis of conmary heart d&se. Tbe dose of mnjugated equine 
estm~ns in the present experiment r&ted in lowr plasma 
w.tmdid coe:ntratkms thzn previw esperiments (320 vs. 
920 pmol/lita, nsp+xiively). Parcotcral administration of er- 
t&f ir liily to provide co~tinooos and consistent hkmd 
c~tnwen conxntrat~s, whereas oral administratfon of am- 
jog&d eqoiw cnrogcns may resuit in inmnsistent and widely 
w&e blood kwlr uf sswdii deocndcnt on the intake of 
aodl a‘nd biowailability. In addition;conjogaad qoine estro 
&ens contain matte different cstrogc~~ It amains ondeter- 
mined wbsther some estrogens am more potent than other in 
their sbilii to act on cownary art&r Therefore, dox of 
cstmws. rwte of administration and diiering potency of 
estro&&may espkia ditlerences in commuy ar&rcs~o&s. 
E&eta of om~stit~s. The ooblic health concern the@ om- 
ggtins may shve;rcy a&cl the cwlffwscular svstcm is b&J 
on the Atldmg that pmgestins, when &nistcrcd with 
estrogens, decrease plma mneenvBtioits of HD’, cholesterol 
(5). However. them arc fw dfrect experimental data togardbtg 
the &cts of pmgeslemttt or pm@stim on cmunmy utcy 
structure or fun&m. It has ken shown (7) that addition of 
proggtenme to an estrogen rqJbxmIcnt regimen dces not 
WIN” the Cxtea of coronary ancty atbcmxleti among 
postmenopaosal monkeys. Forthermmc. pbarmamk@c doren 
of nogesteemne improw cndothcliowttcdiatcd dihtion of 
r&t &onaty a&ics studied in vitro (13). In the pasent 
cxoedment. cwlk hbth dose and continoous la dose MPA 
tw&tentr&ted in~&wnaMPAcottomtmtionsof -2tXlsnd 
M pmowter, Esp-xtiwly. Tbsse hi dme @Bma amantra- 
lions are somewhat lower than those whiewd in women (300 
plssma MPA omcentmtiotts i;‘ntonkc)swoold haw had 
pmfoond efects (i.e., ittbibitkm of estm) on vascolr 
maivitv. Tltc lower MPA mncentralions in monkew would 
not be &ommcnded in women with II utmx~ b&w of 
inwm@etc cndomctrbd protection against cancer. 
It is unclear whether it is rwsonabk to compare the 
cardiovascular elects of progestrmne with tbox of other 
pmgestbts. Haatbo et al. (14) adminislered IWO diLoxt 
1%nottcstostemne-derived pmgestins to sorgkrdly poshtteno~ 
pewal rabbits fed an athemgenic diet. In that rtody. the 
fxogestlns did not r&a HDL cholesterol. and when @WI in 
combbwdion with estradiol did not dimini the heneticinl 
effect of estmdiol on devekpment of amtic athemsclemsis. 
Furthemtore, micronized om~cstemtte does ~4 hwc an HDL 
cholosteml-lowering e&t in women (15). In the present 
experimmt, MPA wns charen becwse it is the pmgcstin most 
commonly prescribed in pos~nenopaosrd hom~oile replsct+ 
ment regbnens in the United States. Adminiktmtion of MPA 
did not a6’ect total p!nsmn or HDL cholesteml mnccntmtkms 
when giuen alone nr in combiin&m with mnjupted eqainc 
estmgsm Howvcr. MPA did diminish the kneticial effect of 
conjugated equine estmgem on endothelium-mediated ilz- 
tinn of athemsclenxic coronzg artcries. This ctTeet wa ub- 
saved whether MPA was given cyclical~ at a relaively high 
dose (IO m&any) or mndnwmsty at a tower dew (2.5 m&q). 
Our results can be reconciled with thux that hwc in&xtcd 
a hamtid e5ect oi pmgestins on plasma lipids. In wxncn (6) 
end monkeys (7). sex hormone replacement cifc;ts on plasma 
lipids explain only 30% of the beneficial ctTectr of ramgen on 
risk of coronary artery disease. Similar results arc rcpurtcd 
(t6) in pamenopausal monkeys given oral contraceptives with 
the sagme amOunts of ethinyl estrtradiml hut ditfcrcm pn~cstinr. 
Dewite an HDL chulestcrul-luwtiin~ ctTcct of mwxxin~ 
pmgcstin diminished the% positive c&t+ raising the pcmi- 
bility of P potentially clinically harmful ctTcct of pmgwin 
rcplaccmcm in ptwmcnoplwl wmcn. 
